Julius Wolf

651 total citations
21 papers, 358 citations indexed

About

Julius Wolf is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Epidemiology. According to data from OpenAlex, Julius Wolf has authored 21 papers receiving a total of 358 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pulmonary and Respiratory Medicine, 6 papers in Oncology and 5 papers in Epidemiology. Recurrent topics in Julius Wolf's work include Lung Cancer Treatments and Mutations (9 papers), Lung Cancer Diagnosis and Treatment (7 papers) and Lung Cancer Research Studies (4 papers). Julius Wolf is often cited by papers focused on Lung Cancer Treatments and Mutations (9 papers), Lung Cancer Diagnosis and Treatment (7 papers) and Lung Cancer Research Studies (4 papers). Julius Wolf collaborates with scholars based in United States, Spain and Italy. Julius Wolf's co-authors include Raymond Yesner, Mary Ellen Patno, Leroy Hyde, Benjamin S. Gordon, Thomas Krause, Nicholas D. D’Esopo, Bernard Roswit, Paul W. Spear, George A. Higgins and Charles E. Eastridge and has published in prestigious journals such as Gastroenterology, Cancer and CHEST Journal.

In The Last Decade

Julius Wolf

20 papers receiving 288 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Julius Wolf United States	9	186	150	83	45	43	21	358
Jiraporn Srinakarin Thailand	9	58 0.3×	118 0.8×	50 0.6×	62 1.4×	15 0.3×	27	331
Hanna Kelly United States	11	83 0.4×	275 1.8×	30 0.4×	61 1.4×	44 1.0×	17	502
Lawrence J. Wolff United States	12	88 0.5×	89 0.6×	104 1.3×	56 1.2×	53 1.2×	23	777
Sema Arıcı Türkiye	12	49 0.3×	90 0.6×	39 0.5×	156 3.5×	75 1.7×	34	364
J. M. Grinyó Spain	10	91 0.5×	46 0.3×	177 2.1×	181 4.0×	20 0.5×	28	551
Jolanta Goździk Poland	12	57 0.3×	97 0.6×	72 0.9×	27 0.6×	33 0.8×	62	385
Miguel Bispo Portugal	11	67 0.4×	106 0.7×	83 1.0×	179 4.0×	30 0.7×	52	355
Edward Passaro United States	11	155 0.8×	149 1.0×	202 2.4×	309 6.9×	15 0.3×	17	520
Muhammet Özer United States	13	58 0.3×	106 0.7×	73 0.9×	78 1.7×	26 0.6×	50	317
Roberta D’Aniello Italy	11	54 0.3×	88 0.6×	45 0.5×	55 1.2×	18 0.4×	26	272

Countries citing papers authored by Julius Wolf

Since Specialization

Citations

This map shows the geographic impact of Julius Wolf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julius Wolf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julius Wolf more than expected).

Fields of papers citing papers by Julius Wolf

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julius Wolf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julius Wolf. The network helps show where Julius Wolf may publish in the future.

Co-authorship network of co-authors of Julius Wolf

This figure shows the co-authorship network connecting the top 25 collaborators of Julius Wolf. A scholar is included among the top collaborators of Julius Wolf based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julius Wolf. Julius Wolf is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wermke, Martin, Valentina Gambardella, Yasutoshi Kuboki, et al.. (2024). OA10.05 Phase I Trial of DLL3/CD3 IgG-Like T-Cell Engager BI 764532 in Patients with DLL3-Positive Tumors: Patients with LCNEC. Journal of Thoracic Oncology. 19(10). S32–S32. 1 indexed citations

Felip, Enriqueta, V. Minotti, Julius Wolf, et al.. (2021). P76.03 Efficacy and Safety of Capmatinib Plus Nivolumab in Pretreated Patients with EGFR Wild-Type Non–Small Cell Lung Cancer. Journal of Thoracic Oncology. 16(3). S585–S586. 4 indexed citations

Felip, Enriqueta, V. Minotti, Ross A. Soo, et al.. (2020). 1284P MET inhibitor capmatinib plus EGFR tyrosine kinase inhibitor nazartinib for EGFR-mutant non-small cell lung cancer. Annals of Oncology. 31. S829–S830. 8 indexed citations

Donhuijsen, K, et al.. (2016). Clinical and morphological aspects of adenocarcinomas of the intestinal type in the inner nose: a retrospective multicenter analysis. European Archives of Oto-Rhino-Laryngology. 273(10). 3207–3213. 4 indexed citations

Taylor, Randall S., Julius Wolf, K. Cullen, et al.. (2007). Early Toxicity and Response Data From a Phase II Trial of Weekly Cetuximab, CBDCA, Paclitaxel, and Daily RT in Patients With Locally Advanced SCCHN. International Journal of Radiation Oncology*Biology*Physics. 69(3). S432–S433. 1 indexed citations

Knapp, Sylvia, et al.. (1994). Hyperkeratotic papular rash in a patient with chronic mucocutaneous candidiasis.. PubMed. 72(3). 198–202.

Yalow, Rosalyn S., Charles E. Eastridge, George A. Higgins, & Julius Wolf. (1979). Plasma and tumor ACTH in carcinoma of the lung. Cancer. 44(5). 1789–1792. 20 indexed citations

Hyde, Leroy, Julius Wolf, Roswell W. Phillips, & William Mietlowski. (1978). Combined Chemotherapy for Squamous Cell Carcinoma of the Lung. CHEST Journal. 73(5). 603–607. 14 indexed citations

Wolf, Julius. (1976). Nitrosoureas as single agents in the treatment of pulmonary cancer.. PubMed. 60(6). 753–6. 9 indexed citations

10.

Hyde, Leroy, et al.. (1973). Natural Course of Inoperable Lung Cancer. CHEST Journal. 64(3). 309–312. 78 indexed citations

11.

Wolf, Julius. (1967). Management of the Patient with Inoperable Bronchogenic Carcinoma. Medical Clinics of North America. 51(2). 563–572. 3 indexed citations

12.

Higgins, George A. & Julius Wolf. (1966). Chemotherapy and lung cancer-present status. Journal of Thoracic and Cardiovascular Surgery. 51(3). 449–454. 3 indexed citations

13.

Wolf, Julius, Mary Ellen Patno, Bernard Roswit, & Nicholas D. D’Esopo. (1966). Controlled study of survival of patients with clinically inoperable lung cancer treated with radiation therapy. The American Journal of Medicine. 40(3). 360–367. 60 indexed citations

14.

Wolf, Julius. (1965). Controlled Studies of the Therapy of Nonresectable Cancer of the Lung: I. Methodology. The Annals of Thoracic Surgery. 1(1). 25–32. 18 indexed citations

15.

Wolf, Julius. (1964). New Tools for Lung Cancer?. Archives of Environmental Health An International Journal. 9(2). 141–142. 1 indexed citations

16.

Gordon, Benjamin S., et al.. (1960). Peliosis Hepatis and Cholestasis Following Administration of Norethandrolone. American Journal of Clinical Pathology. 33(2). 156–165. 64 indexed citations

17.

Wolf, Julius, Paul W. Spear, Raymond Yesner, & Mary Ellen Patno. (1960). Nitrogen mustard and the steroid hormones in the treatment of inoperable bronchogenic carcinoma. The American Journal of Medicine. 29(6). 1008–1016. 55 indexed citations

18.

Wolf, Julius, et al.. (1958). Hospital epidemic of hepatitis. Digestive Diseases and Sciences. 3(6). 436–443. 6 indexed citations

19.

Wolf, Julius, et al.. (1956). Accidental gastric biopsies with the ayre brush. Gastroenterology. 30(4). 686–689. 1 indexed citations

20.

Wolf, Julius, et al.. (1955). Effects of reserpine on gastric secretion.. PubMed. 25(5). 430–8. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact